Indivior | Salg



Sales Endring Dato
AstraZeneca USD 14.89B 1.32B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Glaxosmithkline GBP 8.12B 105M 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Indivior 298M 9M 2024-12
J&J USD 22.52B 49M 2024-12
Kyowa Hakko Kirin JPY 132.76B 2.94B 2024-12
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.56B 386M 2024-12
Pfizer USD 17.76B 61M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12



Indivior Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.